SALKIND GENE purchased 194.7% of their position (241.23K shares) of UPEXI, INC. on the open market
Open‑market purchase worth $550.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/25/2025ACC: 0001477932-25-002979
Director10% Owner
+301.23K
Net shares
Net buyer
$550.0K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
301.23K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+241.23K
Price / share
$2.28
Trade value
$550K
% of position
194.7%
—
123.90K→365.13K
Total
Net shares
+241.23K
Net value
$550K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | P · Purchase | +241.23K | $2.28 | $550K | 194.7% | 123.90K | 365.13K |
| Total | +241.23K | $550K | ||||||
Derivative Transactions2
Options to buy common stock
Direct
Converts to
Common
25K shares
Shares
+25K
Strike price
3.46
Held after
25K
Exercisable
—
—
Options to buy common stock
Direct
Converts to
Common
35K shares
Shares
+35K
Strike price
2.28
Held after
35K
Exercisable
—
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Options to buy common stock Direct | Common25K shares | — | A · Award | +25K | 3.46 | — | 25K |
| Options to buy common stock Direct | Common35K shares | — | A · Award | +35K | 2.28 | — | 35K |